[
    [
        {
            "time": "",
            "orginal_text": "聪投TOP30基金经理4季度最爱调研个股，竟然还是它",
            "features": {
                "keywords": [
                    "基金经理",
                    "调研",
                    "个股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "聪投TOP30基金经理4季度最爱调研个股，竟然还是它",
            "scores": {
                "News_content": "聪投TOP30基金经理4季度最爱调研个股，竟然还是它",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "浦银国际医疗行业2022年展望：关注“创新力+性价比+确定性”三大维度",
            "features": {
                "keywords": [
                    "医疗行业",
                    "创新力",
                    "性价比",
                    "确定性"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "浦银国际医疗行业2022年展望：关注“创新力+性价比+确定性”三大维度",
            "scores": {
                "News_content": "浦银国际医疗行业2022年展望：关注“创新力+性价比+确定性”三大维度",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
            "features": {
                "keywords": [
                    "外资",
                    "增持",
                    "A股",
                    "核心资产"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
            "scores": {
                "News_content": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业周报：IN CHINA FOR GLOBAL 关注中国创新药出海机遇",
            "features": {
                "keywords": [
                    "医药行业",
                    "创新药",
                    "出海"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医药行业周报：IN CHINA FOR GLOBAL 关注中国创新药出海机遇",
            "scores": {
                "News_content": "医药行业周报：IN CHINA FOR GLOBAL 关注中国创新药出海机遇",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-15",
            "orginal_text": "迈瑞医疗12月15日现2笔大宗交易",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "大宗交易"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "迈瑞医疗12月15日现2笔大宗交易",
            "scores": {
                "News_content": "迈瑞医疗12月15日现2笔大宗交易",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]